Literature DB >> 23248338

Retroperitoneal schwannoma with monoclonal plasma cell infiltration: an exceptionally rare collision tumor?

Iswadi Damasena1, Irene Low, Richard Carey-Smith.   

Abstract

Collision tumors within the retroperitoneum are rare. We present the case of a 54-year-old man with an incidental finding of a well-defined iliopsoas mass. He underwent marginal resection via an anterior superior ilio-inguinal approach. Histological examination revealed typical features of a schwannoma surrounded by a notable plasma cell infiltrate. On immunohistochemistry stains, the spindled cells displayed diffuse, strong nuclear and cytoplasmic positivity for S100, whereas epithelial membrane antigen, glial fibrillary acidic protein, and neurofilament stains were uniformly negative. The plasma cell infiltrate was diffusely positive for CD 138, with a majority of them demonstrating positive staining for lambda light chain and negative for kappa light chain. Hematological review found no evidence of marrow plasmacytosis and multiple myeloma was ruled out. At 12 month follow-up, the patient remains free of any recurrence. To our knowledge this is the second case of a schwannoma coexisting with a monoclonal plasma cell infiltrate and the first in the retroperitoneum.

Entities:  

Keywords:  collision tumor; neoplasm; plasma cell tumor; retroperitoneum

Mesh:

Substances:

Year:  2012        PMID: 23248338     DOI: 10.1177/1066896912468612

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

1.  Combined Schwannoma and Kappa-Restricted Plasma Cell Neoplasm: A Case Report and Review of the Literature.

Authors:  Jeffrey John Cannatella; Soumya Pandey
Journal:  Case Rep Pathol       Date:  2021-01-15

2.  Intraosseous schwannoma of the femur in a patient with monoclonal gammopathy of undetermined significance.

Authors:  Timothy McAleese; Kevin Clesham; Darren Moloney; Andrew Hughes; Nazia Faheem; Khalid Merghani
Journal:  Int J Surg Case Rep       Date:  2020-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.